U.S. drugmaker Eli Lilly & Co is beginning a late-stage trial to study whether one of its experimental COVID-19 antibody treatments can prevent the spread of the virus in residents and staff at U.S. nursing homes, it said on Monday.
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co pharmaceuticals group, in Fegersheim, near Strasbourg, France, February 1, 2018. REUTERS/Vincent Kessler
The phase 3 trial will test LY-CoV555, a treatment developed in partnership with Canadian biotech company AbCellera, is expected to enroll up to 2,400 participants who live or work at a facility that has had a recently diagnosed case of COVID-19. The phase 3 nursing homes trial is being conducted in partnership with several long-term care networks across the country as well as the U.S. National Institute of Allergy and Infectious Diseases .
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Lilly begins nursing home trials with antibody drug for COVID-19 preventionUS drugmaker Eli Lilly & Co. says it is beginning a late-stage trial to study whether one of its experimental COVID-19 antibody treatments can prevent the virus' spread in residents and staff in nursing homes.
Weiterlesen »
Eli Lilly Studies Experimental Covid-19 Drug in Nursing HomesThe late-stage trial is exploring whether Eli Lilly’s antibody drug can help reduce infections in senior facilities with a diagnosed case of the new coronavirus.
Weiterlesen »
Eli Lilly starts late-stage study of coronavirus drug in nursing homesU.S. drugmaker Eli Lilly said on Monday it is beginning a late-stage trial to study whether one of its experimental Covid-19 antibody treatments can prevent the virus' spread in residents and staff in U.S. nursing homes.
Weiterlesen »
Eli Lilly launches late-stage antibody treatment trial to be tested in US nursing homesEli Lilly is launching a late-stage study of its monoclonal antibody technology, and has employed a mobile treatment van to deliver this therapy to nursing homes.
Weiterlesen »
What to watch today: Dow to rise as Wall Street monitors D.C. coronavirus relief talksStock futures were higher as Congress negotiates the next relief package and Eli Lilly announces late-stage trial for Covid-19 drug.
Weiterlesen »
Eli Lilly Studies Experimental Covid-19 Drug in Nursing HomesThe late-stage trial is exploring whether Eli Lilly’s antibody drug can help reduce infections in senior facilities with a diagnosed case of the new coronavirus.
Weiterlesen »